Bioinformatics Analysis of Ras Homologue Enriched in the Striatum, a Potential Target for Huntington's Disease Therapy

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2019.4373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts

PLoS ONE
Multidisciplinary
2013English

Functional Heterogeneity of the Striatum in a Rodent Model of Huntington's Disease: Considerations for Neurological Transplantation

Journal of Neural Transplantation and Plasticity
1992English

Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Mining the Potential Therapeutic Targets for Coronary Artery Disease by Bioinformatics Analysis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

siRNA Screen Identifies QPCT as a Druggable Target for Huntington's Disease

Nature Chemical Biology
Cell BiologyMolecular Biology
2015English

OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched With Clinical Outcomes

Microarrays
BiochemistryBioengineeringBiomedical EngineeringBiotechnology
2016English

Screening and Identification of Potential Target Genes in Head and Neck Cancer Using Bioinformatics Analysis

Oncology Letters
Cancer ResearchOncology
2019English

Control of Huntington’s Disease-Associated Phenotypes by the Striatum-Enriched Transcription Factor Foxp2

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

“Huntingtin Holiday”: Progress Toward an Antisense Therapy for Huntington's Disease

Neuron
Neuroscience
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy